The Vanderbilt Institute for Clinical and Translational Research (VICTR) View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2012-2017

FUNDING AMOUNT

2785592 USD

ABSTRACT

The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been established as a vibrant and nurturing home for clinical and translational science. In four years, VICTR has become firmly integrated into the Vanderbilt, Meharry Consortium providing a focus for enhanced clinical and translational research for all disciplines and creating, organizing and making available clinical and translational science tools, methods, resources and educational programs. We have streamlined administrative processes and promoted the translational spirit of the CTSA. The innovations and improvements pursued have enabled both research and researchers to thrive: over 600 investigators were supported by VICTR last year. Through the support of the CTSA, the services offered have been expanded, have been used more frequently and have been used across the consortium. These services have been accessed by all relevant disciplines within Vanderbilt and Meharry and by researchers at every stage of their career. The specific aims of our renewal proposal are to: 1) Systematically remove impediments to research translation; 2) Create and make available novel, research-enabling infrastructure and resources; 3) Train the next generation of investigators; 4) Engage and involve the local community; and 5) Define and continuously measure success in meeting objectives. Contributing to the national CTSA consortium is an objective of VICTR, as the success of the entire program is essential both for its continuity, and for the real societal impact on propelling clinical and translational science. We will continue to contribute in a number of ways, including active service on committees and within the leadership group, sharing of novel methods, and continued development and dissemination of software and tools. In the next grant cycle the VICTR team will continue to propel discoveries and ideas without delay through the spectrum of research to effective translation into clinical practice More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9295096

Related SciGraph Publications

  • 2019-04. CYP2D6 genotype and adverse events to risperidone in children and adolescents in PEDIATRIC RESEARCH
  • 2019-03-27. Adverse Events Associated with Risperidone Use in Pediatric Patients: A Retrospective Biobank Study in DRUGS - REAL WORLD OUTCOMES
  • 2019-01. Brief Report: Differences in Multisensory Integration Covary with Sensory Responsiveness in Children with and without Autism Spectrum Disorder in JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
  • 2018-12. Audiovisual Temporal Processing in Postlingually Deafened Adults with Cochlear Implants in SCIENTIFIC REPORTS
  • 2018-12. A study paradigm integrating prospective epidemiologic cohorts and electronic health records to identify disease biomarkers in NATURE COMMUNICATIONS
  • 2017-12. Traditional healer treatment of HIV persists in the era of ART: a mixed methods study from rural South Africa in BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE
  • 2017-09. Electronic health record-based predictive models for acute kidney injury screening in pediatric inpatients in PEDIATRIC RESEARCH
  • 2017-09. Neural Correlates of Sensory Hyporesponsiveness in Toddlers at High Risk for Autism Spectrum Disorder in JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
  • 2017-06. Predicting Intentional Communication in Preverbal Preschoolers with Autism Spectrum Disorder in JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
  • 2016-09. Engagement of Men in Antenatal Care Services: Increased HIV Testing and Treatment Uptake in a Community Participatory Action Program in Mozambique in AIDS AND BEHAVIOR
  • 2016-08. Attitudes of clinicians following large-scale pharmacogenomics implementation in THE PHARMACOGENOMICS JOURNAL
  • 2016-03. Early Predictors of Growth in Diversity of Key Consonants Used in Communication in Initially Preverbal Children with Autism Spectrum Disorder in JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
  • 2015-12. Realization of a biomechanical model-assisted image guidance system for breast cancer surgery using supine MRI in INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY
  • 2015-12. Benzodiazepine-associated delirium dosing strategy or cumulative dose? in INTENSIVE CARE MEDICINE
  • 2015-12. Predictors of antiretroviral therapy initiation: a cross-sectional study among Chinese HIV-infected men who have sex with men in BMC INFECTIOUS DISEASES
  • 2015-12. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis in ARTHRITIS RESEARCH & THERAPY
  • 2015-08. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012 in JOURNAL OF PERINATOLOGY
  • 2015-07. Integrin β3 Haploinsufficiency Modulates Serotonin Transport and Antidepressant-Sensitive Behavior in Mice in NEUROPSYCHOPHARMACOLOGY
  • 2015-06. Engagement of Traditional Healers and Birth Attendants as a Controversial Proposal to Extend the HIV Health Workforce in CURRENT HIV/AIDS REPORTS
  • 2015-05. Data collection challenges in community settings: insights from two field studies of patients with chronic disease in QUALITY OF LIFE RESEARCH
  • 2014-12. Admixture mapping identifies a locus at 15q21.2–22.3 associated with keloid formation in African Americans in HUMAN GENETICS
  • 2013-06. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry in NATURE GENETICS
  • 2013-04. Respiratory virus multiplex RT-PCR assay sensitivities and influence factors in hospitalized children with lower respiratory tract infections in VIROLOGICA SINICA
  • 2013-03. Diabetes in the Emergency Department and Hospital: Acute Care of Diabetes Patients in CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS
  • 2012-07. Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2012-06. Exome sequencing and the genetic basis of complex traits in NATURE GENETICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2208", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "2785592"
        }, 
        "description": "The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been established as a vibrant and nurturing home for clinical and translational science. In four years, VICTR has become firmly integrated into the Vanderbilt, Meharry Consortium providing a focus for enhanced clinical and translational research for all disciplines and creating, organizing and making available clinical and translational science tools, methods, resources and educational programs. We have streamlined administrative processes and promoted the translational spirit of the CTSA. The innovations and improvements pursued have enabled both research and researchers to thrive: over 600 investigators were supported by VICTR last year. Through the support of the CTSA, the services offered have been expanded, have been used more frequently and have been used across the consortium. These services have been accessed by all relevant disciplines within Vanderbilt and Meharry and by researchers at every stage of their career. The specific aims of our renewal proposal are to: 1) Systematically remove impediments to research translation; 2) Create and make available novel, research-enabling infrastructure and resources; 3) Train the next generation of investigators; 4) Engage and involve the local community; and 5) Define and continuously measure success in meeting objectives. Contributing to the national CTSA consortium is an objective of VICTR, as the success of the entire program is essential both for its continuity, and for the real societal impact on propelling clinical and translational science. We will continue to contribute in a number of ways, including active service on committees and within the leadership group, sharing of novel methods, and continued development and dissemination of software and tools. In the next grant cycle the VICTR team will continue to propel discoveries and ideas without delay through the spectrum of research to effective translation into clinical practice", 
        "endDate": "2017-05-31T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.429651.d", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2423337", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2423337"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "KL2TR000446"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "Meharry", 
          "stage", 
          "effective translation", 
          "novel method", 
          "translational science", 
          "translational science tools", 
          "continuity", 
          "innovation", 
          "investigators", 
          "Vanderbilt Institute", 
          "impediments", 
          "meeting objectives", 
          "leadership group", 
          "administrative processes", 
          "career", 
          "available novel", 
          "Clinical", 
          "software", 
          "services", 
          "delay", 
          "educational programs", 
          "VICTR last year", 
          "infrastructure", 
          "renewal proposal", 
          "clinical practice", 
          "idea", 
          "discovery", 
          "local communities", 
          "Meharry Consortium", 
          "dissemination", 
          "VicTR", 
          "CTSA", 
          "resources", 
          "translation", 
          "Vanderbilt", 
          "sharing", 
          "support", 
          "tool", 
          "entire program", 
          "researchers", 
          "OBJECTIVE", 
          "national CTSA consortium", 
          "active service", 
          "METHODS", 
          "VICTR team", 
          "improvement", 
          "specific aim", 
          "disciplines", 
          "development", 
          "committee", 
          "research", 
          "way", 
          "years", 
          "consortium", 
          "focus", 
          "next grant cycle", 
          "next generation", 
          "success", 
          "translational spirit", 
          "spectrum", 
          "relevant disciplines", 
          "number", 
          "real societal impact", 
          "translational research"
        ], 
        "name": "The Vanderbilt Institute for Clinical and Translational Research (VICTR)", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.412807.8", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.412807.8", 
              "name": "VANDERBILT UNIVERSITY MEDICAL CENTER", 
              "type": "Organization"
            }, 
            "familyName": "BERNARD", 
            "givenName": "GORDON R", 
            "id": "sg:person.01265324116.81", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.01265324116.81", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2423337"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T12:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_4.xml.gz", 
        "startDate": "2012-06-27T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9295096"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2423337'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2423337'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2423337'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2423337'


     

    This table displays all metadata directly associated to this object as RDF triples.

    108 TRIPLES      19 PREDICATES      86 URIs      78 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2423337 schema:about anzsrc-for:2208
    2 schema:amount Neb93c14da1584fcc831dcf15a4faf335
    3 schema:description The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been established as a vibrant and nurturing home for clinical and translational science. In four years, VICTR has become firmly integrated into the Vanderbilt, Meharry Consortium providing a focus for enhanced clinical and translational research for all disciplines and creating, organizing and making available clinical and translational science tools, methods, resources and educational programs. We have streamlined administrative processes and promoted the translational spirit of the CTSA. The innovations and improvements pursued have enabled both research and researchers to thrive: over 600 investigators were supported by VICTR last year. Through the support of the CTSA, the services offered have been expanded, have been used more frequently and have been used across the consortium. These services have been accessed by all relevant disciplines within Vanderbilt and Meharry and by researchers at every stage of their career. The specific aims of our renewal proposal are to: 1) Systematically remove impediments to research translation; 2) Create and make available novel, research-enabling infrastructure and resources; 3) Train the next generation of investigators; 4) Engage and involve the local community; and 5) Define and continuously measure success in meeting objectives. Contributing to the national CTSA consortium is an objective of VICTR, as the success of the entire program is essential both for its continuity, and for the real societal impact on propelling clinical and translational science. We will continue to contribute in a number of ways, including active service on committees and within the leadership group, sharing of novel methods, and continued development and dissemination of software and tools. In the next grant cycle the VICTR team will continue to propel discoveries and ideas without delay through the spectrum of research to effective translation into clinical practice
    4 schema:endDate 2017-05-31T00:00:00Z
    5 schema:funder https://www.grid.ac/institutes/grid.429651.d
    6 schema:identifier N578f1383e9bb4581acd9962e516ddb42
    7 Nc2aaf16dbc5a43c7ac451c6eef41f766
    8 schema:inLanguage en
    9 schema:keywords CTSA
    10 Clinical
    11 METHODS
    12 Meharry
    13 Meharry Consortium
    14 OBJECTIVE
    15 VICTR last year
    16 VICTR team
    17 Vanderbilt
    18 Vanderbilt Institute
    19 VicTR
    20 active service
    21 administrative processes
    22 available novel
    23 career
    24 clinical practice
    25 committee
    26 consortium
    27 continuity
    28 delay
    29 development
    30 disciplines
    31 discovery
    32 dissemination
    33 educational programs
    34 effective translation
    35 entire program
    36 focus
    37 idea
    38 impediments
    39 improvement
    40 infrastructure
    41 innovation
    42 investigators
    43 leadership group
    44 local communities
    45 meeting objectives
    46 national CTSA consortium
    47 next generation
    48 next grant cycle
    49 novel method
    50 number
    51 real societal impact
    52 relevant disciplines
    53 renewal proposal
    54 research
    55 researchers
    56 resources
    57 services
    58 sharing
    59 software
    60 specific aim
    61 spectrum
    62 stage
    63 success
    64 support
    65 tool
    66 translation
    67 translational research
    68 translational science
    69 translational science tools
    70 translational spirit
    71 way
    72 years
    73 schema:name The Vanderbilt Institute for Clinical and Translational Research (VICTR)
    74 schema:recipient N3b8aa29ba6944d3095bcc1330cdaa451
    75 sg:person.01265324116.81
    76 https://www.grid.ac/institutes/grid.412807.8
    77 schema:sameAs https://app.dimensions.ai/details/grant/grant.2423337
    78 schema:sdDatePublished 2019-03-07T12:11
    79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    80 schema:sdPublisher Nc002719cddab42f5b733266e2b176cff
    81 schema:startDate 2012-06-27T00:00:00Z
    82 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9295096
    83 sgo:license sg:explorer/license/
    84 sgo:sdDataset grants
    85 rdf:type schema:MonetaryGrant
    86 N3b8aa29ba6944d3095bcc1330cdaa451 schema:member sg:person.01265324116.81
    87 schema:roleName PI
    88 rdf:type schema:Role
    89 N578f1383e9bb4581acd9962e516ddb42 schema:name nih_id
    90 schema:value KL2TR000446
    91 rdf:type schema:PropertyValue
    92 Nc002719cddab42f5b733266e2b176cff schema:name Springer Nature - SN SciGraph project
    93 rdf:type schema:Organization
    94 Nc2aaf16dbc5a43c7ac451c6eef41f766 schema:name dimensions_id
    95 schema:value 2423337
    96 rdf:type schema:PropertyValue
    97 Neb93c14da1584fcc831dcf15a4faf335 schema:currency USD
    98 schema:value 2785592
    99 rdf:type schema:MonetaryAmount
    100 anzsrc-for:2208 schema:inDefinedTermSet anzsrc-for:
    101 rdf:type schema:DefinedTerm
    102 sg:person.01265324116.81 schema:affiliation https://www.grid.ac/institutes/grid.412807.8
    103 schema:familyName BERNARD
    104 schema:givenName GORDON R
    105 rdf:type schema:Person
    106 https://www.grid.ac/institutes/grid.412807.8 schema:name VANDERBILT UNIVERSITY MEDICAL CENTER
    107 rdf:type schema:Organization
    108 https://www.grid.ac/institutes/grid.429651.d schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...